PYY and metabolic syndrome: In addition, group B (HOMA-IR ≥ 2.5) had significantly more preoperative biomarker abnormalities (other than dyslipidemia) than group A, including leptin, ghrelin, PYY, insulin, RBP4, and LGr (Table 3).